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ABSTRACT 
 
Background: The present study is the first comprehensive report of the Molluscum contagiosum virus (MCV) in 
Iran based on the molecular technique for differentiation and typing of the MCV1 and MCV2. Methods: Patients 
were diagnosed as having tumor-like genital warts less than 5 mm in diameter, and HIV seronegative samples 
were chosen for this cross-sectional study. TaqMan real-time PCR was used to identify MCV following clinical 
examination. Typing of the MCV-positive specimens was performed in the SNP A27451G region of MC021L gene. 
Results: Of 1470 samples, 114 (7.75%) samples were positive for the MCV. From MCV-positive samples, 71.05% 
sequences were found to be related to the MCV1 and 28.95% to the MCV2. Conclusion: This assay constitutes a 
reliable method for identification and typing of the MCV genomic variants that could be valuable for  
reviewing the pathogenesis, molecular epidemiology, and the natural history of MCV-related situations.  
DOI: 10.22034/ibj.22.2.129 
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INTRODUCTION 
 
olluscum contagiosum is a viral infection of 
the epidermis that produces multiple 
umbillicated, tumor-like lesions
[1]
. This 
infection has a worldwide incidence, and the 
typical mode of transmission is via direct human 
contact, including sexual means or contaminated 
fomites
[2]
. Molluscum contagiosum usually affects 
children but is often associated with immune-
suppressed patients with insufficient cellular 
immunity
[3,4]
. Molluscum contagiosum virus (MCV) is 
polymorphic and consists of genomic variants that 
cluster into two different genetic subtypes, MCV1 and 
MCV2, each with some variants that have similar 
patterns of symptoms and occur at similar anatomical 
sites of the body and have no variant-specific gender 
preference
[5]
. There is a substantial conserved genetic 
structure between MCV1 and MCV2. However, there 
is a 12-kilo base region specific to MCV1 and a 2-3-
kilo base deletion in MCV2
[6]
. The importance of the 
alteration between the subtypes is weakly understood, 
though zonal and age variations in the frequency of the 
MCV subtypes have previously been reported
[7]
. 
MCV1 is the most common infection, while MCV2 
may be more widespread in immunocompromised 
patients
[8,9]
. Clinically, Molluscum can be confused 
with skin disorders caused by other pathogens such as 
herpes simplex virus, varicella zoster virus, and human 
papillomavirus (HPV), especially in immune-
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compromised individuals such as HIV patients
[10]
. 
MCV can cause a cytopathic effect in some tissue 
culture lines
[11]
. The identification of MCV is 
commonly done clinically. The requirement for 
laboratory diagnosis MCV is contemplative, since a 
spontaneous healing is perceived in cases where no 
underlying immune defect is present. The disease is 
deliberated as a self-limiting situation, which deserves 
no more medical attention than an aesthetic 
nuisance
[12]
. Consequently, identification of the disease 
is more valuable when there is an impressive 
management modality available for the clinician. The 
genital lesions should be treated in order to break the 
chain of sexual communication and/or auto-
inoculation. When all these features take into account, 
the practitioner might consider the laboratory diagnosis 
before starting treatment
[13]
.  
PCR-based assays are the best choice for the decisive 
diagnosis of MCV. An extra advantage of molecular 
diagnosis is that the results provide data about the 
subtype of the infecting Molluscum strain
[14]
. No 
molecular data have been presented in the literature 
regarding MCV subtypes prevalent in Iran. Hence, in 
the present study, we tried to document the possibility 
of DNA amplification-based assay in the clinical 
laboratory. This study showed that the first report on 
the leading Molluscum contagiosum subtypes 
widespread among the Iranian population. 
 
 
MATERIALS AND METHODS 
 
Study design and population 
A total of 1470 Iranian patients (821 females and 649 
males aged between 3 and 55) admitted to Firoozgar 
Hospital in Tehran, Iran between January 2012 to July 
2015. Patients who met the inclusion criteria, i.e. 
patients diagnosed by a general physician or 
dermatologist as having genital warts caused by HPV 
or/and MCV and are seronegative for the HIV, were 
eligible for entrance in our cross-sectional study. 
Female patients with pre-study Pap smear displaying a 
high-grade squamous intraepithelial lesion greater than 
5 mm in diameter and pregnant or lactating women 
were excluded from our study. Informed consents were 
obtained from all participants. Studies included at least 
one category from three groups. Sample sizes were 
more than 350 cases for each classification group. 
According to questionnaires form, 495 cases were 
classified into immunocompromised patients (group 1), 
581 patients had unprotected sexual activities (group 
2), and 394 people had the history of swimming in a 
swimming pool. Some of them were children aged 
between 5-15 years old who did not cover visible 
lesions and shared individual instrument such as towel 
with other friends (group 3). Clinical diagnosis was 
made in each case according to the morphological and 
clinical features of the lesions. The number and the 
distribution of lesions  were recorded. Cryotherapy was 
administered to each lesion during the therapy session 
as a part of routine anti-Molluscum treatment protocol. 
After the first visit and treatment, the patients were 
advised to return for weekly follow-ups  in order to 
assess the success of the treatment regimen. Complete 
healing was determined as the complete 
epithelialization and regaining the normal skin 
appearance at the location of the lesions. The lesions 
resisting the first treatment, as determined on the fourth 
visit, were subjected to another cryotherapy. In cases 
where clinical diagnosis was difficult to reach, lesions 
were sprayed with ethyl chloride and/or liquid 
nitrogen. Biopsies from the skin lesions of each patient 
were cut-off with a sterilized scalpel and placed in 1 ml 
PBS. Total DNA was extracted from tissue using the 
NucleoSpin
®
 Tissue Kit (Macherey-Nagel, GmbH 
and Co, Düren, Germany) according to the 
manufacturer’s instructions. Validation of the DNA 
quality was performed with the specific amplification 
of β-globin gene
[15]
. 
 
Detection of the MCV in the specimens  
TaqMan real-time PCR assay targeting the MC021L 
gene of the MCV was performed. Designed primers 
and probe by Trama et al.
[14]
 were proposed for the 
assay. In detail, they reported the primers and probe 
designed according to the conserved region of the 
MCV1 and MCV2. All primers and probes were 
purchased from Bioneer Co., Ltd. (Daejeon, 
Korea).The reactions included 10 µl template DNA (50 
ng/µl), 1 µl each primer (300 nM), 0.5 µl probe (200 
nM), 12.5 µl Premix Ex Taq™ (Probe qPCR; Takara 
Bio, Shiga, Japan), and ROX plus (Takara, Japan). The 
thermal cycles were carried out in an Exicycler
TM
 96 
Real-Time Quantitative Thermal Block (Bioneer, 
Korea). The temperature profile was 95 °C for 2 min, 
95 °C for 20 s, and 60 °C for 45 s for 40 cycles with 
the FAM and JOE reporter. Furthermore, negative 
samples for the MCV were examined by specific 
MY09/MY11 and GP5+/GP6 + primers of HPV
[16]
.  
 
MCV1 and MCV2 typing 
Variable regions of MC021L gene (variable between 
the different types of MCV) were used for molecular 
typing of MCV. Nucleotide sequences of the target 
virus (accession numbers HE977596, HE977595, 
U60315, M63486, HE977606, and M63487) were 
utilized for primer design by using NCBI Primer 
BLAST online software (https://www.ncbi.nlm.nih. 
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gov/tools/primer-blast/). The forward and reverse 
primers sequences were as follows: 5′-CAAGATT 
GTAGAGACGCTGC-3′ and 5′-GTAGTGCGTGCC 
GTCCATGT-3′. The forward and reverse primers 
annealed to the highly conserved regions of 36-55 and 
995-1014 of complete coding DNA sequence of 
MC021L gene (accession no. HE977596), respectively. 
PCR was performed on the MCV-positive genome. 
The 979-bp fragment was amplified using 1.5 mM 
MgCl2, 0.2 mM dNTP, 1U Taq DNA polymerase, 10 
PCR buffer (SinaClon BioScience Co., Iran), 0.5 mM 
of each primer, and 50 ng MCV genomic DNA . The 
thermal cycler was run at 95 °C for 1 min, 55 °C for 1 
min, 72 °C for 1 min for 40 cycles, and 72 °C for 10 
min. 
 
 
RESULTS 
 
Of 1470 samples, 114 (7.75%) were positive for the 
MCV, 1253 (85.24%) were positive for HPV, and 103 
(7.0%) were negative for both the HPV and MCV. The 
resulted PCR products were subjected to direct Sanger 
dideoxy DNA sequencing with described MC021L 
typing primers. Sequencing data were first evaluated 
with BLASTn online software (https://blast.ncbi.nlm. 
nih.gov/Blast.cgi?PAGE_TYPE=BlastSearch). The 
results showed 99-100% homology of obtained 
sequences with MC021L gene of the MCV. The 
nucleotide sequence in the single nucleotide 
polymorphism A27451G helps distinguish between the 
MCV1 and MCV2 
[14]
. This approach was sufficient to 
discriminate between MCV1 and MCV2 by comparing 
the expected sequences, but not to identify MCV1 or 
MCV2 via BLASTn online tool. 
Finally, the sequence typing of samples was 
performed with the CLC Sequence viewer (version 6.4; 
CLC Bio Co., Aarhus, Denmark). The MCV reference 
sequences were obtained from the GenBank with 
accessions numbers of NC_001731, MCU60315, and 
M63486 for the MCV1 and accession number of 
M63487 for the MCV2. Overall, among 114 positive 
samples for the MCV, 81 sequences (71.05%) 
corresponded to MCV1 and 33 sequences (28.95%) 
matched MCV2, equating to a 2.45:1 MCV1:MCV2 
ratio. In accordance with the gender (male or female), 
the clinical samples were divided into three age groups. 
The number and distribution of the MCV subtypes 
according to the ages of the subjects are presented in 
Figure 1. The maximum percentages of the MCV1 
were observed in males of ages 16-30, 5-15, and 31-55 
years and females of ages 31-55, 5-15, and 16-30 
years, respectively. However, the maximum 
percentages of the MCV2 in the different ages of males 
and females were 31-55 years, 16-30 years, and 5-15 
years, respectively. Of 114 MCV-positive samples, 27 
patients were classified into immunocompromised 
patients (group 1), 61 patients had unprotected sexual 
activities (group 2), and 26 people had the history of 
swimming in a swimming pool (group 3). On the basis 
of this fact, the highest incidence rate of the MCV1 and 
MCV2 were related to the patients who had 
unprotected sexual activities. The results are 
summarized in Figure 2. Furthermore, the maximum 
frequency rates of the MCV1 were observed in the 
female patients, and the greatest rate of the MCV2 
were recorded in the male patients. All sequences were 
deposited in the GenBank with accession numbers of 
KT289406-KT289519. 
 
 
DISCUSSION 
 
Here, we describe a molecular screening and typing 
of the MCV-specific MC021L PCR assay among 
Iranian patients, initially established by Trama et al.
[14]
. 
The results of this study show the possibility  
of   performing   dependable   and   decisive  laboratory 
 
 
 
        
  
 
 
Fig. 1. Male (A) and female (B) subtype classification of the 
MCV positive clinical specimen based on patient gender and 
age. 
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Fig. 2. Male (A), and female (B) systematic arranging of the 
MCV1 and MCV2 on the basis of immunocompromised patients 
(Group 1), unprotected sexual activities (Group 2), and history 
of the swimming pool (Group 3). 
 
 
identification of Molluscum contagiosum with a 
molecular method during the routine flow of a 
dermatological practice. The present study, in 
significance levels, can correspond to different findings 
of MCV- and HPV-induced mucosal/cutaneous 
lesions, at least in the anogenital region (particularly in 
children), where both types of lesions can be found and 
misdiagnosed. There are incompatible reports 
regarding the rate of CMV subtypes derived from 
patients. Saral et al.
[13]
 observed MCV1 only in 
Turkish population. Porter et al.
[17]
  reported that the 
ratio of MCV1 to MCV2 was 3.23:1, and no MCV1 
infection was discovered in the patients less than 15 
years of age. Equally, in an earlier study,  
MCV1 was 1.75 times more predominant than 
MCV2
[18]
. However, Agromayor and colleagues
[19]
 
found an enormous MCV1 infection in a Spanish 
population with a ratio of 146:1 for MCV1 to MCV2.  
Yamashita et al.
[20]
 assessed 171 Japanese patients 
using molecular epidemiologic analysis. In their study, 
MCV1 was commonly detected in children (98%) and 
adult women (92%), while MCV2 was more frequently 
isolated from adult men (44%) and from patients with 
HIV infection (75%). Our results support the previous 
decision of a high frequency and global distribution of 
MCV1. In this sense, the high prevalence of the MCV1 
in clinical samples occurred in the female patients aged 
31-55 years (28.07%), in the men aged 16-30 (9.65%), 
and in cases who had unprotected sexual behavior 
(7.4%). In contrast, the predominance subtypes of the 
MCV2 were in male clinical samples in the age range 
of 31-55 years (20.17%), as well as in those who had 
unprotected sexual manners (3.09%) and in 
immunocompromised patients (5.45%). These results 
are in agreement with Yamashita et al.'s
[20]
 results, 
suggesting that the possible transmission route of 
MCV2 is sexual interaction, especially among 
immunocompromised patients. The disagreements 
between reported studies might have derived from the 
methodologies used by different researches. However, 
the local differences also might be the reason for some 
of the discrepancies in the infection rates affected by 
various subtypes.  
In Iran, there are limited numbers of publications 
about the prevalence of the MCV among Iranian 
population with a narrow range of sampling size. Also, 
there are no studies that discriminate between the 
MCV1 and MCV2. However, the current research 
involved a greater number of lesions samples, 
providing valuable documents on the epidemiology of 
MCV infection between our patients. To the best of our 
knowledge, the present study is the first comprehensive 
report on MCV infection using molecular technique for 
differentiation and typing of the MCV1 and MCV2 in 
different cases (immunocompromised patients, people 
with unprotected sexual activity, and patients who had 
a history of swimming in a swimming pool) and ages 
(5-55 years). However, this study had some restrictions 
that are its cross-sectional design and the absence of 
representation of the overall population. 
In conclusion, the method can be considered as 
having sufficient specificity to identify the widest 
range of MCV variants. Finally, this assay may be 
valuable for reviewing the pathogenesis, molecular 
epidemiology, and natural history of MCV-related 
situations. 
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